Page 61 - 73_01

VOL. 73 (1), 97-124, 2007 RNA INTERFERENTE: DEL DESCUBRIMIENTO A SUS APLICACIONES

(36) BITKO, V.; MUSIYENKO, A.; SHULYAYEVA, O. and BARIK, S. (2005): Inhibition of
(37) respiratory viruses by nasally administered siRNA. Nat. Med. 11: 50-55.
(38) Tompkins, S. M.; Lo, C. Y.; Tumpey, T. M. and Epstein, S. L. (2004): Protec-
(39) tion against lethal influenza virus challenge by RNA interference in vivo.
(40) Proc. Natl. Acad. Sci. USA. 101: 8682-8686.
(41) LAKATOS, L.; CSORBA, T.; PANTALEO, V.; CHAPMAN, E. J.; CARRINGTON, J. C.; LIU, Y.
(42) P. et al. (2006): Small RNA binding is a common strategy to suppress RNA
(43) silencing by several viral suppressors. EMBO J. 25: 2768-2780.
(44) SULLIVAN, C. S.; GRUNDHOFF, A. T.; TEVETHIA, S.; PIPAS, J. M. and GANEM, D.
(45) (2005): SV40-encoded microRNAs regulate viral gene expression and reduce
(46) susceptibility to cytotoxic T cells. Nature. 435: 682-686.
(47) GRUNDHOFF, A.; SULLIVAN, C. S. and GANEM, D. (2006): A combined computa-
(48) tional and microarray-based approach identifies novel microRNAs encoded
(49) by human gamma-herpes viruses. RNA. 12: 733-750.
(50) PFEFFER, S.; SEWER, A.; LAGOS-QUINTANA, M.; SHERIDAN, R.; SANDER, C.; GRASSER,
F. A. et al. (2005): Identification of microRNAs of the herpes virus family.
(51) Nat. Methods. 2: 269-276.
MORRISSEY, D. V.; LOCKRIDGE, J. A.; SHAW, L.; BLANCHARD, K.; JENSEN, K.; BREEN,
W. et al. (2005): Potent and persistent in vivo anti-HBV activity of chemically
modified siRNAs. Nat. Biotechnol. 23: 1002-1007.
HAMMOND, S. M. (2006): RNAi, microRNAs, and human disease. Cancer Che-
mother. Pharmacol. 58: 63-68.
KRUTZFELDT, J.; RAJEWSKY, N.; BRAICH, R.; RAJEEV, K. G.; TUSCHL, T.; MANOHARAN,
M. et al. (2005): Silencing of microRNAs in vivo with «antagomirs». Nature.
438: 685-689.
BOUDREAU, R. L. and DAVIDSON, B. L. (2006): RNAi therapy for neurodegene-
rative diseases. Curr. Top. Dev. Biol. 75: 73-92.
ZIMMERMANN, T. S.; LEE, A. C., AKINC, A.; BRAMLAGE, B.; BUMCROT, D.; FEDORUK,
M. N. et al. (2006): RNAi-mediated gene silencing in non-human primates.
Nature. 441: 111-114.
SIJEN, T.; VIJN, I.; REBOCHO, A.; VAN BLOKLAND, R.; ROELOFS, D.; MOL, J. N. et al.
(2001): Transcriptional and posttranscriptional gene silencing are mechanis-
tically related. Curr. Biol. 11: 436-440.
METTE, M. F.; AUFSATZ, W.; VAN DER WINDEN, J.; MATZKE, M. A. and MATZKE, A.
J. (2000): Transcriptional silencing and promoter methylation triggered by
double-stranded RNA. EMBO J. 19: 5194-5201.
HALL, I. M.; SHANKARANARAYANA, G. D.; NOMA, K.; AYOUB, N.; COHEN, A. and
GREWAL, S. I. (2002): Establishment and maintenance of a heterochromatin
domain. Science. 297: 2232-2237.
KETTING, R. F.; HAVERKAMP, T. H.; VAN LUENEN, H. G. and PLASTERK, R. H.
(1999): Mut-7 of C. elegans, required for transposon silencing and RNA inter-
ference, is a homolog of Werner syndrome helicase and RNaseD. Cell. 99:
133-141.
TABARA, H.; SARKISSIAN, M.; KELLY, W. G.; FLEENOR, J.; GRISHOK, A.; TIMMONS, L.
et al. (1999): The rde-1 gene, RNA interference, and transposon silencing in
C. elegans. Cell. 99: 123-132.

123